Hong Huang, Jie Hou, Liyu Rao, Zerui Chen, Borong Shu, Hongwei Liang
Guangdong General Hospital's Nan Hai Hospital.
The Second People's Hospital of Nan Hai District Foshan City, China.
Medicine (Baltimore). 2019 Oct;98(43):e17531. doi: 10.1097/MD.0000000000017531.
Lymph node metastasis (LNM) of esophageal squamous cell carcinoma (ESCC) has important prognostic significance. In this study, we examined the correlations between lymph node metastatic sites and prognosis in patients with resectable ESCC.A total of 960 patients who received curative esophagectomy with systemic lymphadenectomy between 1996 and 2014 were included in the retrospective analysis. The Kaplan-Meier method and log-rank test were used to perform the survival analysis. The prognostic significance of LNM site was evaluated by Cox regression analysis.The LNM in middle paraesophageal (P < .001), subcarinal (P < .001), lower paraesophageal (P < .001), recurrent laryngeal nerve (P = .012), paratracheal (P = .014), and perigastric (P < .001) sites were associated with poor prognosis in univariate analysis. In multivariate analysis, only middle paraesophageal LNM (MPLNM, P = .017; HR, 1.33; 95%CI, 1.05-1.67) was the independent factor for worse prognosis. Additionally, patients with MPLNM had a lower 5-year survival rate (15.6%) than those with LNM at other sites. Furthermore, upper or middle tumor location and relatively late pN stage were associated with increased risk of MPLNM.Our findings suggested MPLNM could be a characteristic indicating the worst prognosis. Preoperative examinations should identify the existences of MPLNM, especially on patients with risk factors. And patients with MPLNM should be considered for more aggressive multidisciplinary therapies.
食管鳞状细胞癌(ESCC)的淋巴结转移(LNM)具有重要的预后意义。在本研究中,我们探讨了可切除性ESCC患者淋巴结转移部位与预后之间的相关性。
对1996年至2014年间接受根治性食管切除术并系统性淋巴结清扫术的960例患者进行回顾性分析。采用Kaplan-Meier法和对数秩检验进行生存分析。通过Cox回归分析评估LNM部位的预后意义。
单因素分析显示,食管中段旁(P<0.001)、隆突下(P<0.001)、食管下段旁(P<0.001)、喉返神经(P=0.012)、气管旁(P=0.014)和胃周(P<0.001)部位的LNM与预后不良相关。多因素分析显示,只有食管中段旁LNM(MPLNM,P=0.017;HR,1.33;95%CI,1.05-1.67)是预后较差的独立因素。此外,MPLNM患者的5年生存率(15.6%)低于其他部位LNM患者。此外,肿瘤位于上或中段以及相对较晚的pN分期与MPLNM风险增加相关。
我们的研究结果表明,MPLNM可能是预后最差的一个特征。术前检查应确定MPLNM的存在,尤其是有危险因素的患者。对于MPLNM患者,应考虑采取更积极的多学科治疗。